PortfoliosLab logoPortfoliosLab logo
IBRX vs. APLD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IBRX vs. APLD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ImmunityBio, Inc. (IBRX) and Applied Digital Corporation (APLD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IBRX achieves a 264.65% return, which is significantly higher than APLD's 84.34% return. Over the past 10 years, IBRX has underperformed APLD with an annualized return of 1.77%, while APLD has yielded a comparatively higher 127.82% annualized return.


IBRX

1D
-1.90%
1M
0.00%
YTD
264.65%
6M
218.06%
1Y
151.57%
3Y*
38.97%
5Y*
-12.44%
10Y*
1.77%

APLD

1D
-2.98%
1M
-1.46%
YTD
84.34%
6M
62.71%
1Y
337.56%
3Y*
77.44%
5Y*
105.95%
10Y*
127.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBRX vs. APLD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IBRX
ImmunityBio, Inc.
264.65%-22.66%-49.00%-0.99%-16.61%-54.39%251.72%226.72%-74.16%-21.50%
APLD
Applied Digital Corporation
84.34%220.94%13.35%266.30%-56.09%11,789.90%389.44%-34.55%64.99%-33.33%

Correlation

The correlation between IBRX and APLD is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.31

Correlation (3Y)
Calculated over the trailing 3-year period

0.27

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (10Y)
Calculated over the trailing 10-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Jul 28, 2015

0.15

The correlation between IBRX and APLD shifts across timeframes, from 0.15 (all time) to 0.31 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

IBRX:

$7.41B

APLD:

$12.28B

EPS

IBRX:

-$0.89

APLD:

-$0.72

PS Ratio

IBRX:

49.31

APLD:

30.64

Total Revenue (TTM)

IBRX:

$140.98M

APLD:

$390.57M

Gross Profit (TTM)

IBRX:

$132.23M

APLD:

$124.93M

EBITDA (TTM)

IBRX:

-$196.14M

APLD:

-$154.66M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBRX vs. APLD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBRX
IBRX Risk / Return Rank: 8383
Overall Rank
IBRX Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
IBRX Sortino Ratio Rank: 8585
Sortino Ratio Rank
IBRX Omega Ratio Rank: 8282
Omega Ratio Rank
IBRX Calmar Ratio Rank: 8787
Calmar Ratio Rank
IBRX Martin Ratio Rank: 8080
Martin Ratio Rank

APLD
APLD Risk / Return Rank: 9393
Overall Rank
APLD Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
APLD Sortino Ratio Rank: 9292
Sortino Ratio Rank
APLD Omega Ratio Rank: 8888
Omega Ratio Rank
APLD Calmar Ratio Rank: 9595
Calmar Ratio Rank
APLD Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBRX vs. APLD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ImmunityBio, Inc. (IBRX) and Applied Digital Corporation (APLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IBRXAPLDDifference
Sharpe ratioReturn per unit of total volatility

-1.73

Sortino ratioReturn per unit of downside risk

-0.76

Omega ratioGain probability vs. loss probability

1.31

1.39

-0.07

Calmar ratioReturn relative to maximum drawdown

3.60

6.76

-3.16

Martin ratioReturn relative to average drawdown

6.15

16.62

-10.46

IBRX vs. APLD - Sharpe Ratio Comparison

The current IBRX Sharpe Ratio is 1.46, which is lower than the APLD Sharpe Ratio of 3.19. The chart below compares the historical Sharpe Ratios of IBRX and APLD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IBRX vs. APLD - Drawdown Comparison

The maximum IBRX drawdown since its inception was -97.30%, roughly equal to the maximum APLD drawdown of -99.73%. Use the drawdown chart below to compare losses from any high point for IBRX and APLD.


Loading charts...

Drawdown Indicators


IBRXAPLDDifference

Max Drawdown

Largest peak-to-trough decline

-97.30%

-99.73%

+2.43%

Max Drawdown (1Y)

Largest decline over 1 year

-42.34%

-50.31%

+7.97%

Max Drawdown (3Y)

Largest decline over 3 years

-79.34%

-76.66%

-2.68%

Max Drawdown (5Y)

Largest decline over 5 years

-91.75%

-82.61%

-9.14%

Max Drawdown (10Y)

Largest decline over 10 years

-97.03%

-89.80%

-7.23%

Current Drawdown

Current decline from peak

-82.91%

-8.96%

-73.95%

Average Drawdown

Average peak-to-trough decline

-84.38%

-74.78%

-9.60%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.76%

20.43%

+4.33%

Volatility

IBRX vs. APLD - Volatility Comparison

The current volatility for ImmunityBio, Inc. (IBRX) is 18.35%, while Applied Digital Corporation (APLD) has a volatility of 30.09%. This indicates that IBRX experiences smaller price fluctuations and is considered to be less risky than APLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IBRXAPLDDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.35%

30.09%

-11.74%

Volatility (6M)

Calculated over the trailing 6-month period

88.53%

77.05%

+11.48%

Volatility (1Y)

Calculated over the trailing 1-year period

104.49%

106.79%

-2.30%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

113.44%

165.10%

-51.66%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

111.42%

301.63%

-190.21%

Dividends

IBRX vs. APLD - Dividend Comparison

Neither IBRX nor APLD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

IBRX vs. APLD - Financials Comparison

This section allows you to compare key financial metrics between ImmunityBio, Inc. and Applied Digital Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M20222023202420252026
44.21M
161.76M
(IBRX) Total Revenue
(APLD) Total Revenue
Values in USD except per share items

Frequently Asked Questions


IBRX and APLD have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

APLD has higher volatility (30.09%) compared to IBRX (18.35%). In terms of maximum drawdown, IBRX dropped -97.30% vs APLD's -99.73%.

APLD currently has the higher Sharpe Ratio (3.19 vs 1.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBRX and APLD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer